Retatrutide 10 mg

Retatrutide 10 mg

180 $

Retatrutide is a 39-amino-acid triple agonist engineered to activate the GLP-1, GIP, and glucagon receptors simultaneously, making it one of the most pharmacologically complex incretin-class compounds available for laboratory study. This 10 mg vial is supplied as a lyophilized powder for in vitro and preclinical research into multi-receptor energy balance pathways.

Specifications

Product: Retatrutide 10 mg
Form: Lyophilized powder
Purity: High purity research grade
Use: Research use only

Storage

Store refrigerated at 2–8°C. For long-term storage, keep frozen according to laboratory protocols. Protect from heat, moisture, and direct light.

Package Includes

1 × Sterile research vial

Category: Tag:

Description

Unlike single- or dual-receptor incretin compounds, retatrutide’s triple-agonist design allows researchers to study the interplay between GLP-1-driven appetite signaling, GIP-mediated insulin sensitivity, and glucagon receptor-linked thermogenesis within a single experimental model. Investigators use this compound to examine energy expenditure, lipid metabolism, and hepatic fat pathways in cell-based and animal research systems, and to compare multi-receptor agonism against mono- and dual-agonist incretin peptides.

Research Applications

  • Multi-receptor incretin pathway studies (GLP-1R / GIPR / GCGR)
  • Energy expenditure and thermogenesis research
  • Hepatic lipid metabolism models
  • Comparative studies against GLP-1 and GIP/GLP-1 dual agonists
  • Receptor desensitization and chronic exposure research
COA download
Disclaimer

For laboratory research use only. Not for human consumption, clinical use, veterinary use, diagnosis, or therapeutic application.

Reviews

There are no reviews yet.

Be the first to review “Retatrutide 10 mg”

Your email address will not be published. Required fields are marked *

Related products